{"id":17334,"date":"2025-07-08T13:00:28","date_gmt":"2025-07-08T13:00:28","guid":{"rendered":"https:\/\/itbt-staging-68b209.ingress-earth.ewp.live\/?p=17334"},"modified":"2025-07-08T13:00:28","modified_gmt":"2025-07-08T13:00:28","slug":"chugai-and-gero-join-forces-on-aging-disease-therapies","status":"publish","type":"post","link":"https:\/\/demo.itbusinesstoday.com\/ja\/health-tech\/pharma\/chugai-and-gero-join-forces-on-aging-disease-therapies\/","title":{"rendered":"\u4e2d\u5916\u88fd\u85ac\u3068\u4e0b\u5442\u88fd\u85ac\u3001\u52a0\u9f62\u75be\u60a3\u6cbb\u7642\u3067\u63d0\u643a"},"content":{"rendered":"<p>\u4e2d\u5916\u88fd\u85ac\u682a\u5f0f\u4f1a\u793e\u3068\u30b7\u30f3\u30ac\u30dd\u30fc\u30eb\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696dGero PTE.LTD.LTD.\u3068\u5171\u540c\u7814\u7a76\u304a\u3088\u3073\u30e9\u30a4\u30bb\u30f3\u30b9\u5951\u7d04\u3092\u7de0\u7d50\u3057\u305f\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u672c\u5951\u7d04\u306f\u3001\u52a0\u9f62\u95a2\u9023\u75be\u60a3\u306b\u5bfe\u3059\u308b\u65b0\u305f\u306a\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u3092\u76ee\u7684\u3068\u3059\u308b\u3082\u306e\u3067\u3059\u3002<\/p>\n<p>\u4e2d\u5916\u88fd\u85ac\u306f\u3001\u672c\u5171\u540c\u7814\u7a76\u3067\u72ec\u81ea\u306e\u6297\u4f53\u5de5\u5b66\u6280\u8853\u3092\u6d3b\u7528\u3057\u307e\u3059\u3002\u4e2d\u5916\u88fd\u85ac\u306f\u3001Gero\u304c\u7279\u5b9a\u3057\u305f\u75be\u60a3\u30e1\u30ab\u30cb\u30ba\u30e0\u3092\u30bf\u30fc\u30b2\u30c3\u30c8\u3068\u3059\u308b\u65b0\u3057\u3044\u6297\u4f53\u533b\u85ac\u306e\u5275\u88fd\u3092\u76ee\u6307\u3057\u307e\u3059\u3002Gero\u306eAI\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u30d2\u30c8\u306e\u81a8\u5927\u306a\u30c7\u30fc\u30bf\u30bb\u30c3\u30c8\u3092\u89e3\u6790\u3059\u308b\u3053\u3068\u3067\u3001\u3053\u308c\u3089\u306e\u6a19\u7684\u3092\u898b\u3064\u3051\u307e\u3059\u3002Gero\u306f\u4e2d\u5916\u88fd\u85ac\u306b\u72ec\u5360\u7684\u306a\u30b0\u30ed\u30fc\u30d0\u30eb\u6a29\u5229\u3092\u4ed8\u4e0e\u3002\u4e2d\u5916\u88fd\u85ac\u306f\u3001Gero\u304c\u767a\u898b\u3057\u305f\u6297\u4f53\u533b\u85ac\u306e\u7814\u7a76\u30fb\u958b\u767a\u30fb\u88fd\u9020\u30fb\u8ca9\u58f2\u3092\u884c\u3046\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002<\/p>\n<p>\u8ca1\u52d9\u6761\u4ef6\u306b\u306f\u3001Gero\u793e\u3078\u306e\u5951\u7d04\u4e00\u6642\u91d1\u304c\u542b\u307e\u308c\u307e\u3059\u3002\u307e\u305f\u3001\u7d04$2\u51045,000\u4e07\u306b\u9054\u3059\u308b\u53ef\u80fd\u6027\u306e\u3042\u308b\u30de\u30a4\u30eb\u30b9\u30c8\u30fc\u30f3\u652f\u6255\u3044\u3082\u3042\u308a\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u652f\u6255\u3044\u306f\u3001\u4e00\u5b9a\u306e\u958b\u767a\u304a\u3088\u3073\u5546\u696d\u4e0a\u306e\u76ee\u6a19\u3092\u9054\u6210\u3057\u305f\u5834\u5408\u306b\u652f\u6255\u308f\u308c\u307e\u3059\u3002\u307e\u305f\u3001\u4e2d\u5916\u88fd\u85ac\u306f\u3001\u5c06\u6765\u306e\u88fd\u54c1\u8ca9\u58f2\u306b\u5bfe\u3059\u308b\u30ed\u30a4\u30e4\u30eb\u30c6\u30a3\u3092\u652f\u6255\u3046\u4e88\u5b9a\u3067\u3059\u3002<\/p>\n<h4>\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a class=\"p-url\" href=\"https:\/\/itbt-staging-68b209.ingress-earth.ewp.live\/health-tech\/pharma\/alpha-fusion-curadh-mtr-partner-on-astatine-211-drugs\/\" rel=\"bookmark\">\u30a2\u30eb\u30d5\u30a1\u30fb\u30d5\u30e5\u30fc\u30b8\u30e7\u30f3\u793e\u3068Curadh MTR\u793e\u304c\u30a2\u30b9\u30bf\u30c1\u30f3211\u88fd\u5264\u3067\u63d0\u643a<\/a><\/h4>\n<p>\u4e2d\u5916\u88fd\u85ac\u306e\u793e\u9577\u517cCEO\u3067\u3042\u308b\u5965\u7530 \u6cbb\u306f\u3001\u4e2d\u5916\u88fd\u85ac\u306e\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u652f\u3048\u308b\u91cd\u8981\u306a\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u306b\u3064\u3044\u3066\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u307e\u3057\u305f\u3002\u4e2d\u5916\u88fd\u85ac\u306e\u4ee3\u8868\u53d6\u7de0\u5f79\u793e\u9577\u3067\u3042\u308b\u5965\u7530 \u6cbb\u306f\u3001\u4e2d\u5916\u88fd\u85ac\u306e\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u652f\u3048\u308b\u91cd\u8981\u306a\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u306b\u3064\u3044\u3066\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u4eca\u56de\u306e\u63d0\u643a\u306f\u3001\u4e0b\u5442\u85ac\u54c1\u306e\u5275\u85ac\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3068\u4e2d\u5916\u88fd\u85ac\u306e\u958b\u767a\u6280\u8853\u3092\u878d\u5408\u3057\u3001\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u63a8\u3057\u9032\u3081\u308b\u3082\u306e\u3067\u3059\u3002\"<\/p>\n<p>Gero\u793e\u306e\u30d4\u30fc\u30bf\u30fc\u30fb\u30d5\u30a7\u30c7\u30a3\u30c1\u30a7\u30d5\u6700\u9ad8\u7d4c\u55b6\u8cac\u4efb\u8005\uff08CEO\uff09\u306f\u3001\"\u5f53\u793e\u306eAI\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u52a0\u9f62\u95a2\u9023\u75be\u60a3\u3068\u8001\u5316\u306e\u91cd\u8981\u306a\u6a19\u7684\u3092\u898b\u3064\u3051\u307e\u3059\u3002\"\u3068\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u4e2d\u5916\u88fd\u85ac\u3068\u306e\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u306f\u3001\u79c1\u305f\u3061\u304c\u6d1e\u5bdf\u3092\u6cbb\u7642\u6cd5\u306b\u5909\u3048\u308b\u306e\u306b\u5f79\u7acb\u3061\u307e\u3059\u3002\u79c1\u305f\u3061\u306e\u76ee\u6a19\u306f\u3001\u5931\u308f\u308c\u305f\u6a5f\u80fd\u3092\u56de\u5fa9\u3055\u305b\u308b\u3053\u3068\u3067\u3059\u3002\"<\/p>\n<p>\u30a2\u30ec\u30c3\u30af\u30b9\u30fb\u30ab\u30c7\u30c3\u30c8\u6700\u9ad8\u7d4c\u55b6\u8cac\u4efb\u8005 <a href=\"https:\/\/www.gero.ai\/\">\u4e0b\u5442<\/a>\u3068\u306e\u63d0\u643a\u306b\u8208\u596e\u3057\u3066\u3044\u307e\u3059\u3002 <a href=\"https:\/\/www.chugai-pharm.co.jp\/\">\u4e2d\u5916\u88fd\u85ac<\/a>.\u79c1\u305f\u3061\u306f\u3001\u30c7\u30fc\u30bf\u99c6\u52d5\u578b\u306e\u6a19\u7684\u63a2\u7d22\u3068\u5148\u9032\u7684\u306a\u6cbb\u7642\u30c7\u30b6\u30a4\u30f3\u3092\u878d\u5408\u3055\u305b\u307e\u3059\u3002\u79c1\u305f\u3061\u306f\u3001\u5897\u52a0\u3059\u308b\u52a0\u9f62\u95a2\u9023\u75be\u60a3\u306e\u4eba\u3005\u306e\u305f\u3081\u306b\u3001\u4e00\u6d41\u306e\u6cbb\u7642\u6cd5\u3092\u5275\u9020\u3059\u308b\u3053\u3068\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002\"<\/p>","protected":false},"excerpt":{"rendered":"<p>Chugai Pharmaceutical Co., Ltd. and Singapore-based biotechnology firm Gero PTE. LTD. Gero has announced a joint research and license agreement. This agreement aims to develop new treatments for age-related diseases. Chugai will use its unique antibody engineering technologies in this collaboration. They want to make new antibody drugs that target disease mechanisms identified by Gero. Gero\u2019s AI platform finds these targets by analyzing big human datasets. Gero gives Chugai exclusive global rights. They can research, develop, manufacture, and sell antibody drugs from these discoveries. The financial terms involve an upfront payment to Gero. There are also milestone payments that could reach about $250 million. These payments depend on meeting certain [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":17335,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[89,207,237,182],"tags":[218,3503,2637,6036,424,6035],"ppma_author":[572],"class_list":["post-17334","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-tech","category-international","category-news","category-pharma","tag-ai","tag-biotechnology","tag-chugai-pharmaceutical","tag-gero","tag-pharma","tag-pharmaceutical-product"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Chugai, Gero Partner to Tackle Age-Related Diseases<\/title>\n<meta name=\"description\" content=\"Chugai and Gero signed a joint research deal to develop innovative therapies targeting age-related diseases through advanced biotechnology.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/demo.itbusinesstoday.com\/ja\/health-tech\/pharma\/chugai-and-gero-join-forces-on-aging-disease-therapies\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Chugai, Gero Partner to Tackle Age-Related Diseases\" \/>\n<meta property=\"og:description\" content=\"Chugai and Gero signed a joint research deal to develop innovative therapies targeting age-related diseases through advanced biotechnology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/demo.itbusinesstoday.com\/ja\/health-tech\/pharma\/chugai-and-gero-join-forces-on-aging-disease-therapies\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-08T13:00:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/Chugai-and-Gero-Enter-into-Joint-Research-and-License-Agreement-to-Develop-Novel-Therapies-for-Age-Related-Diseases.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Chugai, Gero Partner to Tackle Age-Related Diseases","description":"Chugai and Gero signed a joint research deal to develop innovative therapies targeting age-related diseases through advanced biotechnology.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/demo.itbusinesstoday.com\/ja\/health-tech\/pharma\/chugai-and-gero-join-forces-on-aging-disease-therapies\/","og_locale":"ja_JP","og_type":"article","og_title":"Chugai, Gero Partner to Tackle Age-Related Diseases","og_description":"Chugai and Gero signed a joint research deal to develop innovative therapies targeting age-related diseases through advanced biotechnology.","og_url":"https:\/\/demo.itbusinesstoday.com\/ja\/health-tech\/pharma\/chugai-and-gero-join-forces-on-aging-disease-therapies\/","og_site_name":"itbusinesstoday","article_published_time":"2025-07-08T13:00:28+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/Chugai-and-Gero-Enter-into-Joint-Research-and-License-Agreement-to-Develop-Novel-Therapies-for-Age-Related-Diseases.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/demo.itbusinesstoday.com\/health-tech\/pharma\/chugai-and-gero-join-forces-on-aging-disease-therapies\/#article","isPartOf":{"@id":"https:\/\/demo.itbusinesstoday.com\/health-tech\/pharma\/chugai-and-gero-join-forces-on-aging-disease-therapies\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/demo.itbusinesstoday.com\/#\/schema\/person\/65e0b9dff93040ce4cd1ec0fb09d4cb3"},"headline":"Chugai and Gero Join Forces on Aging Disease Therapies","datePublished":"2025-07-08T13:00:28+00:00","mainEntityOfPage":{"@id":"https:\/\/demo.itbusinesstoday.com\/health-tech\/pharma\/chugai-and-gero-join-forces-on-aging-disease-therapies\/"},"wordCount":273,"publisher":{"@id":"https:\/\/demo.itbusinesstoday.com\/#organization"},"image":{"@id":"https:\/\/demo.itbusinesstoday.com\/health-tech\/pharma\/chugai-and-gero-join-forces-on-aging-disease-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/Chugai-and-Gero-Enter-into-Joint-Research-and-License-Agreement-to-Develop-Novel-Therapies-for-Age-Related-Diseases.webp","keywords":["AI","Biotechnology","Chugai Pharmaceutical","Gero","Pharma","pharmaceutical product"],"articleSection":["Health Tech","International","News","Pharma"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/demo.itbusinesstoday.com\/health-tech\/pharma\/chugai-and-gero-join-forces-on-aging-disease-therapies\/","url":"https:\/\/demo.itbusinesstoday.com\/health-tech\/pharma\/chugai-and-gero-join-forces-on-aging-disease-therapies\/","name":"Chugai, Gero Partner to Tackle Age-Related Diseases","isPartOf":{"@id":"https:\/\/demo.itbusinesstoday.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/demo.itbusinesstoday.com\/health-tech\/pharma\/chugai-and-gero-join-forces-on-aging-disease-therapies\/#primaryimage"},"image":{"@id":"https:\/\/demo.itbusinesstoday.com\/health-tech\/pharma\/chugai-and-gero-join-forces-on-aging-disease-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/Chugai-and-Gero-Enter-into-Joint-Research-and-License-Agreement-to-Develop-Novel-Therapies-for-Age-Related-Diseases.webp","datePublished":"2025-07-08T13:00:28+00:00","description":"Chugai and Gero signed a joint research deal to develop innovative therapies targeting age-related diseases through advanced biotechnology.","breadcrumb":{"@id":"https:\/\/demo.itbusinesstoday.com\/health-tech\/pharma\/chugai-and-gero-join-forces-on-aging-disease-therapies\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/demo.itbusinesstoday.com\/health-tech\/pharma\/chugai-and-gero-join-forces-on-aging-disease-therapies\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/demo.itbusinesstoday.com\/health-tech\/pharma\/chugai-and-gero-join-forces-on-aging-disease-therapies\/#primaryimage","url":"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/Chugai-and-Gero-Enter-into-Joint-Research-and-License-Agreement-to-Develop-Novel-Therapies-for-Age-Related-Diseases.webp","contentUrl":"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/07\/Chugai-and-Gero-Enter-into-Joint-Research-and-License-Agreement-to-Develop-Novel-Therapies-for-Age-Related-Diseases.webp","width":1200,"height":800,"caption":"Chugai Pharmaceutical"},{"@type":"BreadcrumbList","@id":"https:\/\/demo.itbusinesstoday.com\/health-tech\/pharma\/chugai-and-gero-join-forces-on-aging-disease-therapies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/demo.itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Chugai and Gero Join Forces on Aging Disease Therapies"}]},{"@type":"WebSite","@id":"https:\/\/demo.itbusinesstoday.com\/#website","url":"https:\/\/demo.itbusinesstoday.com\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/demo.itbusinesstoday.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/demo.itbusinesstoday.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/demo.itbusinesstoday.com\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/demo.itbusinesstoday.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/demo.itbusinesstoday.com\/#\/schema\/logo\/image\/","url":"https:\/\/itbt-staging-68b209.ingress-earth.ewp.live\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbt-staging-68b209.ingress-earth.ewp.live\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/demo.itbusinesstoday.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/demo.itbusinesstoday.com\/#\/schema\/person\/65e0b9dff93040ce4cd1ec0fb09d4cb3","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.pngb2476e2e1c1c4874e4c5d81a934febfb","url":"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbt-staging-68b209.ingress-earth.ewp.live\/"],"url":"https:\/\/demo.itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/demo.itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/17334","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=17334"}],"version-history":[{"count":1,"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/17334\/revisions"}],"predecessor-version":[{"id":17336,"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/17334\/revisions\/17336"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/17335"}],"wp:attachment":[{"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=17334"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=17334"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=17334"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/demo.itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=17334"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}